BUPIVACAINE HYDROCHLORIDE INJECTION, USP
BUPIVACAINE HYDROCHLORIDE INJECTION, USP
Approved
DIN Number
02488930
Drug Class
Human
Market Date
Aug 15, 2022
Company
HC
baxter corporation
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02488930
AIG Number0108896002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
N01BB01 BUPIVACAINE
Product Specifications
Dosage FormSolution
Route of AdministrationEpidural
,
Retrobulbar
AHFS Classification72:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
BUPIVACAINE HYDROCHLORIDEActive
Strength: 7.5 MG / ML
Monograph: BUPIVACAINE HYDROCHLORIDE